Varaico: Literature-Extracted Genetic Variants

Gene:ATP1A3
Variant:p.G316S
Back to variants list

ATP1A3

NM_152296.5:p.G316S

Associated Papers

Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.

Haq IU et al.

Movement Disorders : Official Journal of the Movement Disorder Society, 2025

Neurological and psychiatric characterization of rapid-onset dystonia-parkinsonism over time.

Haq IU et al.

Parkinsonism & Related Disorders, 2025

Alternating hemiplegia of childhood: a distinct clinical entity and ATP1A3-related disorders: A narrative review.

Pavone P et al.

Medicine, 2022

ConVarT: a search engine for matching human genetic variants with variants from non-human species.

Pir MS et al.

Nucleic Acids Research, 2022

34718716 (PubMed )
Supplement: gkab939_supplemental_files.zip › Table_S11.xls › Sheet1

ATP1A3 mutation in rapid-onset dystonia parkinsonism: New data and genotype-phenotype correlation analysis.

Yu L et al.

Frontiers in Aging Neuroscience, 2022

Genetically altered animal models for ATP1A3-related disorders.

Ng HWY et al.

Disease Models & Mechanisms, 2021

Early role for a Na+,K+-ATPase (ATP1A3) in brain development.

Smith RS et al.

Proceedings of the National Academy of Sciences of the United States of America, 2021

34161264 (PubMed )
Supplement: pnas.2023333118.sapp.pdf

ATP1A3 variants and slowly progressive cerebellar ataxia without paroxysmal or episodic symptoms in children.

Sasaki M et al.

Developmental Medicine and Child Neurology, 2021

ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.

Salles PA et al.

Frontiers in Neurology, 2021

Auditory Neuropathy as the Initial Phenotype for Patients With ATP1A3 c.2452 G > A: Genotype-Phenotype Study and CI Management.

Wang W et al.

Frontiers in Cell and Developmental Biology, 2021

Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.

Arystarkhova E et al.

Neurobiology of Disease, 2019

A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblings.

Gu F et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2019

30700791 (PubMed )
Supplement: NIHMS1521482-supplement-Large_Excel_File_1.xlsx › ConfirmedDiagnosesAgreed

CRISPR-Cas9 human gene replacement and phenomic characterization in Caenorhabditis elegans to understand the functional conservation of human genes and decipher variants of uncertain significance.

McDiarmid TA et al.

Disease Models & Mechanisms, 2018

ATP1A3 Mutation in Adult Rapid-Onset Ataxia.

Sweadner KJ et al.

Plos One, 2016

Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models.

Holm TH et al.

Frontiers in Physiology, 2016

In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C. elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects.

Sorkaç A et al.

Plos One, 2016

Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations.

de Gusmao CM et al.

Movement Disorders Clinical Practice, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."